| Name | ROR1 antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have demonstrated that the long non‐coding RNA ROR1‑AS1 is aberrantly expressed in several malignancies and appears to play pivotal roles in cancer progression and patient prognosis. In hepatocellular carcinoma, for instance, ROR1‑AS1 is upregulated and its elevated expression is significantly associated with advanced clinical stage, tumor invasiveness, and poor overall survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, research in bladder cancer has implicated ROR1‑AS1 in cancer progression, suggesting its potential as an important clinical marker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther investigations have expanded these findings to cancers such as cervical cancer and lung malignancies. In cervical cancer, emerging evidence hints at a key oncogenic role for ROR1‑AS1, although the precise mechanisms remain to be fully elucidated."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In non‑small‑cell lung cancer, ROR1‑AS1 is not only upregulated but functionally contributes to tumor cell viability and invasion via modulation of the PI3K/Akt/mTOR pathway, as knockdown studies have revealed significant reductions in cell proliferation and increased apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Furthermore, observations in lung adenocarcinoma reinforce its oncogenic potential."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies highlight the multifunctional nature of ROR1‑AS1. In osteosarcoma, for example, ROR1‑AS1 acts as a competing endogenous RNA by sponging miR‑504, thereby promoting cell cycle progression, proliferation, and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Likewise, exosomal ROR1‑AS1 derived from cancer‑associated fibroblasts has been shown to modulate ferroptosis in lung cancer cells, underscoring its role in tumor cell survival and resistance to cell death."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Finally, in cholangiocarcinoma, upregulation of ROR1‑AS1 is associated with enhanced cell proliferation, migration, and a shorter overall survival, suggesting that it may represent a promising target for future diagnostic and therapeutic strategies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ze Zhang, Shouqian Wang, Fan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2019.7398"}], "href": "https://doi.org/10.3892/or.2019.7398"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31746401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31746401"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Qingke Chen, Lingmin Fu "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0227568"}], "href": "https://doi.org/10.1371/journal.pone.0227568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31929567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31929567"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Longyu Zhang, Zhaolian Wei, Ying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ROR1-AS1 enhances STC2-mediated cell growth and autophagy in cervical cancer through miR-670-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Recept Signal Transduct Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/10799893.2020.1836495"}], "href": "https://doi.org/10.1080/10799893.2020.1836495"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33081599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33081599"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Fengbo Li, Fengming Gu, Qian Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem Mol Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbt.22726"}], "href": "https://doi.org/10.1002/jbt.22726"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33491326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33491326"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Nan Xu, Lixing Qiao, Liping Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2019)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31983094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31983094"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xiangkun Wu, Lihua Yan, Yongxi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103498"}], "href": "https://doi.org/10.18632/aging.103498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33401251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33401251"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fei Yao, Yongxiang Zhao, Guangyao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2024.111221"}], "href": "https://doi.org/10.1016/j.cellsig.2024.111221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38729321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38729321"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Xueliang Li, Zhaowei Sun, Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ROR1-AS1 might promote in vivo and in vitro proliferation and invasion of cholangiocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-023-11412-1"}], "href": "https://doi.org/10.1186/s12885-023-11412-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37770853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37770853"}]}]}]}
|
| NCBI Gene ID | 101927034 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ROR1-AS1 has 8 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 3 datasets.
Click the + buttons to view associations for ROR1-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CellMarker Gene-Cell Type Associations | cell types associated with ROR1-AS1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ROR1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ROR1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |